Literature DB >> 24188978

MRI reveals brain abnormalities in drug-naive Parkinson's disease.

Peggy J Planetta1, Nikolaus R McFarland, Michael S Okun, David E Vaillancourt.   

Abstract

Most brain studies of Parkinson's disease (PD) focus on patients who are already taking antiparkinsonian medication. This makes it difficult to isolate the effects of disease from those of treatment. We review magnetic resonance imaging evidence supporting the hypothesis that early-stage untreated PD patients have structural and functional abnormalities in the brain, some of which are related to motor symptoms.

Entities:  

Mesh：

Year:  2014        PMID： 24188978      PMCID： PMC3885158          DOI： 10.1249/JES.0000000000000003

Source DB:  PubMed          Journal:  Exerc Sport Sci Rev        ISSN： 0091-6331            Impact factor:   6.230


  39 in total

1.  Neurophysiological investigation of the basis of the fMRI signal.

Authors:  N K Logothetis; J Pauls; M Augath; T Trinath; A Oeltermann
Journal:  Nature       Date:  2001-07-12       Impact factor: 49.962

2.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

3.  Parkinson's disease: the thalamic components of the limbic loop are severely impaired by alpha-synuclein immunopositive inclusion body pathology.

Authors:  U Rüb; K Del Tredici; C Schultz; E Ghebremedhin; R A I de Vos; E Jansen Steur; H Braak
Journal:  Neurobiol Aging       Date:  2002 Mar-Apr       Impact factor: 4.673

4.  Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water.

Authors:  Sheng-Kwei Song; Shu-Wei Sun; Michael J Ramsbottom; Chen Chang; John Russell; Anne H Cross
Journal:  Neuroimage       Date:  2002-11       Impact factor: 6.556

Review 5.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

6.  Pharmacologically modulated fMRI--cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients.

Authors:  C Buhmann; V Glauche; H J Stürenburg; M Oechsner; C Weiller; C Büchel
Journal:  Brain       Date:  2003-02       Impact factor: 13.501

7.  Ageing and Parkinson's disease: substantia nigra regional selectivity.

Authors:  J M Fearnley; A J Lees
Journal:  Brain       Date:  1991-10       Impact factor: 13.501

8.  Prognostic significance of the onset mode in parkinsonism.

Authors:  A H Rajput; R Pahwa; P Pahwa; A Rajput
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

9.  Long term treatment and disease severity change brain responses to levodopa in Parkinson's disease.

Authors:  T Hershey; K J Black; J L Carl; L McGee-Minnich; A Z Snyder; J S Perlmutter
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

10.  Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI.

Authors:  K Yoshikawa; Y Nakata; K Yamada; M Nakagawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154
View more
  7 in total

1.  Altered Recruitment of Motor Cortex Neuronal Activity During the Grasping Phase of Skilled Reaching in a Chronic Rat Model of Unilateral Parkinsonism.

Authors:  Brian I Hyland; Sonja Seeger-Armbruster; Roseanna A Smither; Louise C Parr-Brownlie
Journal:  J Neurosci       Date:  2019-10-22       Impact factor: 6.167

2.  Evaluating rehabilitation interventions in Parkinson's disease with functional MRI: a promising neuroprotective strategy.

Authors:  Carlo Augusto Mallio; Bruno Beomonte Zobel; Carlo Cosimo Quattrocchi
Journal:  Neural Regen Res       Date:  2015-05       Impact factor: 5.135

3.  Prehension synergies and hand function in early-stage Parkinson's disease.

Authors:  Hang Jin Jo; Jaebum Park; Mechelle M Lewis; Xuemei Huang; Mark L Latash
Journal:  Exp Brain Res       Date:  2014-11-05       Impact factor: 1.972

4.  Characterizing structural neural networks in de novo Parkinson disease patients using diffusion tensor imaging.

Authors:  S Nigro; R Riccelli; L Passamonti; G Arabia; M Morelli; R Nisticò; F Novellino; M Salsone; G Barbagallo; A Quattrone
Journal:  Hum Brain Mapp       Date:  2016-07-28       Impact factor: 5.038

5.  T2-relaxometry predicts outcome of DBS in idiopathic Parkinson's disease.

Authors:  Tarja Lönnfors-Weitzel; Thilo Weitzel; Johannes Slotboom; Claus Kiefer; Claudio Pollo; Michael Schüpbach; Markus Oertel; Alain Kaelin; Roland Wiest
Journal:  Neuroimage Clin       Date:  2016-09-29       Impact factor: 4.881

6.  Beta-band oscillations in the supplementary motor cortex are modulated by levodopa and associated with functional activity in the basal ganglia.

Authors:  Jae Woo Chung; Roxana G Burciu; Edward Ofori; Stephen A Coombes; Evangelos A Christou; Michael S Okun; Christopher W Hess; David E Vaillancourt
Journal:  Neuroimage Clin       Date:  2018-05-18       Impact factor: 4.881

7.  Microstructural damage of the cortico-striatal and thalamo-cortical fibers in Fabry disease: a diffusion MRI tractometry study.

Authors:  Sirio Cocozza; Simona Schiavi; Giuseppe Pontillo; Matteo Battocchio; Eleonora Riccio; Simona Caccavallo; Camilla Russo; Teodolinda Di Risi; Antonio Pisani; Alessandro Daducci; Arturo Brunetti
Journal:  Neuroradiology       Date:  2020-07-22       Impact factor: 2.804
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.